61 employees
NexImmune is a biopharmaceutical company developing novel immuno-therapeutics based on the proprietary artificial immune technology.
2011
$50M
from 1 investors over 1 rounds
NexImmune, Inc. raised $50M on January 8, 2021
Investors: Irving Investors